gemcitabine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awasthi, K; Chen, Y; Johnson, RM; Miller, KLR; Rapp, CM; Sahu, RP; Thyagarajan, A; Travers, JB | 1 |
1 other study(ies) available for gemcitabine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Topical application of gemcitabine generates microvesicle particles in human and murine skin.
Topics: Animals; Gemcitabine; Humans; Mice; Platelet Activating Factor; Receptors, G-Protein-Coupled; Skin; Skin Neoplasms | 2022 |